Condition
Prostate Cancer Stage
Total Trials
6
Recruiting
2
Active
2
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 6 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (4)
Early P 1 (1)
Trial Status
Unknown2
Recruiting2
Completed1
Not Yet Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT06419348Early Phase 1RecruitingPrimary
99mTc-QULIC-5-P1 SPECT Imaging in Patients With Prostate Cancer
NCT05902637Not ApplicableCompleted
The Efficacy of Mapping for Cognitive Prostate Biopsy
NCT06662708Not ApplicableNot Yet Recruiting
Artificial Intelligence Models for Precision Prediction and Treatment of Prostate Cancer
NCT06497283Not ApplicableRecruiting
Binaural Sound for Remimazolam Maintenance
NCT05427864Not ApplicableUnknown
Comparison of Multiparametric Prostate MRI and Ga-68 PSMA PET Imaging in Prostate Cancer Staging
NCT03507595Unknown
Evaluation of the Metastasis and Recurrence of Prostate Cancer
Showing all 6 trials